Ocrelizumab (Ocrevus) Subcutaneous Injection
Ocrelizumab, known under the brand name Ocrevus, is a disease-modifying therapy that targets specific immune cells involved in MS progression. Scientific advancements have led to a revolutionary new medium of delivering this treatment via a jab, which takes just minutes compared to previous infusions that could last multiple hours.